SciELO - Scientific Electronic Library Online

 
vol.63 número2Uso de tocilizumab en pacientes hospitalizados durante la primera ola de la pandemia COVID-19Cimicifuga racemosa (L.) Nutt. en el tratamiento de los síntomas vasomotores de la menopausia: revisión índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Ars Pharmaceutica (Internet)

versión On-line ISSN 2340-9894

Resumen

BONILLA-PLAZA, Jaime Andrés et al. Lower back pain after iodine-131-6-β-iodomethyl-19-norcholesterol injection: a case report. Ars Pharm [online]. 2022, vol.63, n.2, pp.173-177.  Epub 25-Abr-2022. ISSN 2340-9894.  https://dx.doi.org/10.30827/ars.v63i2.23505.

The [131I]Iodine-6-β-iodomethyl-19-norcholesterol ([131I]Norcholesterol; NP-59), is indicated in the diagnosis of the functional state of adrenal cortical tissue, in the detection of functional tissue in hyperadrenocorticalism as well as in primary aldosteronism. We present the case of a 54-year-old woman, referred for evaluation of suspected aldosteronism, and who immediately after intravenous administration of [131I]Norcholesterol suffered a strong adverse drug reaction, with dizziness, flushing, increased blood pressure, chest tightness, low back pain and erythematous rash up to 9 days after injection. Symptoms resolved satisfactorily after administration of antihistamines and corticosteroids. This reaction was suspected to be related to the administration of [131I]Norcholesterol caused by a type I allergic reaction.

Palabras clave : NP-59; adverse drug reaction; pharmacovigilance.

        · resumen en Español     · texto en Español     · Español ( pdf )